尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Palasis Maria. Insider active across 2 companies, notably Beta Bionics, Inc.. Aggregated, 8 disclosures have been published. Split: 0 buy · 3 sells. Total volume traded: €65k. Activity tracked since 16 October 2024. The latest transaction was disclosed on 21 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Palasis Maria is a declarant linked to Beta Bionics, Inc., where she is Director, and to Lyra Therapeutics, Inc., where she is President & CEO. She has 4 filings in total, and the 4 sampled filings run from 2024-10-18 to 2026-05-26, with buy and sell amounts of EUR 0 each, and the most frequent transaction nature being Attribution.